https://www.aaem.pl/-Borrelia-miyamotoi-DNA-in-a-patient-suspected-of-Lyme-borreliosis
Borrelia miyamotoi DNA in a patient suspected of Lyme borreliosis
Ann Agric Environ Med. 2025;32(1):142-145
Article (PDF, 771.39 kB)
ABSTRACT
Introduction and Objective.
Manifestations of infection caused by Borrelia miyamotoi can mimic highly variable symptoms of Lyme borreliosis. The aim of the study was to detect DNA from B. miyamotoi samples from patients with suspected neuroborreliosis.
Materials and Method. Samples of blood serum and cerebrospinal fluid (CSF) were collected from 133 patients. Diagnosis was established by the detection of specific antibodies to Borrelia burgdorferi sensu lato (s.l.) with ELISA and immunoblot. All Borrelia-positive samples were tested by nested PCR for the B. miyamotoi and B. burgdorferi s.l. DNA.
Results. B. miyamotoi DNA was detected in the CSF of one (0.8%) patient. DNA of B. burgdorferi s.l. was not found in any samples.
Conclusions. Detection of the B. miyamotoi in patients with central nervous system infections expand the development of knowledge on infections caused by Borrelia spirochetes.
_______________
**Comment**
Just like STARI, B. miyamotoi looks, smells, and feels just like Lyme but will never be picked up on standard CDC 2-tiered testing for Lyme.
While there are both PCR and antibody tests for Borrelia miyamotoi, they are offered at specialty labs which many mainstream doctors just assume are pure evil because that’s what the CDC has beat into their heads for decades.
For more:
- https://madisonarealymesupportgroup.com/2020/11/18/what-you-need-to-know-about-borrelia-miyamotoi/
- https://madisonarealymesupportgroup.com/2021/08/06/what-is-borrelia-miyamotoi/
“In vitro analysis has shown the susceptibility of B. miyamotoi to ceftriaxone, azithromycin, and doxycycline, with resistance to amoxicillin,” the authors explain.
- https://madisonarealymesupportgroup.com/2020/06/17/borrelia-miyamotoi-infection-in-a-highly-endemic-area-of-lyme-disease/
- https://madisonarealymesupportgroup.com/2020/12/31/lyme-disease-are-we-looking-for-the-wrong-culprit/
- https://madisonarealymesupportgroup.com/2020/12/14/how-many-negative-lyme-tests-are-due-to-b-miyamotoi/
Since Borrelia miyamotoi is not a reportable illness to the CDC, no one has any clue about prevalence but reports are coming in continually that it’s highly likely to be a much bigger problem than ‘authorities’ believe.
It was recently discovered that:
- Among positive ticks, 60% were for B. miyamotoi.
- Testing on over 2,000 humans (mainly late stage/chronic patients) showed 30% negative results and 70% positive, among which over 60% indicated the presence of specific Borrelia miyamotoi phages. https://madisonarealymesupportgroup.com/2020/11/30/neglected-infections-gastrointestinal-issues-in-patients-with-late-vector-borne-infections/
- https://madisonarealymesupportgroup.com/2020/10/24/a-case-of-borrelia-miyamotoi/
- https://madisonarealymesupportgroup.com/2018/02/15/b-miyamotoi-in-ca-ticks-for-a-long-time/
- https://madisonarealymesupportgroup.com/2023/05/10/californias-first-cdc-confirmed-case-of-borrelia-miyamotoi/
- https://madisonarealymesupportgroup.com/2017/09/14/bm-in-manitoba-2011-2014/
- https://madisonarealymesupportgroup.com/2019/12/01/c6-peptide-test-for-lyme-disease-may-indicate-borrelia-miyamotoi-infection/
- https://madisonarealymesupportgroup.com/2022/11/07/meningoencephalitis-due-to-borrelia-miyamotoi/
- https://madisonarealymesupportgroup.com/2022/03/29/borrelia-miyamotoi-found-in-3-5-of-new-england-blood-samples-tens-of-thousands-possibly-infected/
Madison Area Lyme Support Group 